Intelligent medication delivery systems and methods using a prescription-regulated software application
Systems, devices and methods are disclosed for a prescription-regulated software application and an associated medical device. In some aspects, a smart medicine-injection device (e.g., smart insulin pen) is configured to be in communication with a patient's companion device (e.g., smartphone) having a software application (prescription app) that serves the patient as a complimentary medical device to the smart medicine-injection device, in which only certain features and functionalities of the prescription app are fully operable based on device pairing with the smart medicine-injection device to unlock medical device capabilities only available to the patient through prescription.
1. A method for providing a medically-prescribed software application, comprising:
obtaining, at a mobile device, a software application associated with a medical device, wherein the software application includes one or more prescription-regulated operational features that, when executed, cause the mobile device to operate in a manner that is regulated to require a medical prescription for use of the software application;
initially launching, at the mobile device, the software application, wherein the one or more prescription-regulated operational features of the software application are inoperable by default;
receiving, at the mobile device, a wireless signal from the medical device to pair the medical device to the mobile device for intermittent and/or periodic communications;
receiving, at the mobile device during pairing of the medical device with the mobile device, prescription data stored on the medical device, the prescription data configured to enable as operable the prescription-regulated operational features of the software application; and
enabling, at the mobile device, the one or more prescription-regulated operational features of the software application as operable using the prescription data received at the mobile device from the medical device during pairing of the medical device with the mobile device.
2. The method of claim 1 , wherein the received wireless signal includes a security code, and wherein the method comprises storing the security code in a memory of mobile device.
3. The method of claim 2 , wherein the security code is a unique security code that only corresponds to a patient user who has been prescribed the medical device.
4. The method of claim 2 , comprising:
transmitting, by the mobile device, the security code to a remote server to validate the security code; and
receiving, by the mobile device, validation data from the remote server to authorize activation of the one or more prescription-regulated operational features of the software application.
5. The method of claim 1 , wherein the received wireless signal includes a validation code included in a pairing protocol, and wherein the enabling includes processing the validation code to compare to a predetermined authorization code contained within the obtained software application.
6. The method of claim 1 , wherein the medical device includes a medicine injection pen and/or medicine injection pump.
7. The method of claim 1 , wherein the mobile device is implemented on a smartphone, a tablet, and/or a wearable device.
8. The method of claim 1 , wherein the software application is operable on the mobile device to cause the mobile device to display a default screen prior to enabling as operable the one or more prescription-regulated operational features.
9. The method of claim 8 , wherein the default screen includes one or more of an indicator that the pairing is undergoing, a list of trouble-shooting steps should the pairing be impaired or unsuccessful, or a contact information for a user to seek assistance with the pairing process.
10. The method of claim 1 , wherein the wireless signal is received using a Bluetooth, Bluetooth Low Energy (BLE), and/or Near Field Communication (NFC) protocol.
11. A method for enabling use of a medically-regulated software application for a mobile device with a medically-prescribed injection device, the method comprising:
determining that the medically-prescribed injection device is within a communication range of the mobile device so as to allow wireless communications between the medically-prescribed injection device and the mobile device;
at the mobile device, launching the medically-regulated software application having one or more prescription-regulated operational features that are inoperable by default, wherein the one or more prescription-regulated operational features, when executed, cause the mobile device to operate in a manner that is regulated to require a medical prescription for use of the medically-regulated software application;
at the mobile device, receiving a wireless transmission from the medically-prescribed injection device to pair the medically-prescribed injection device with the mobile device;
receiving, at the mobile device during pairing of the medically-prescribed injection device with the mobile device, prescription data stored on the medically-prescribed injection device, the prescription data indicative that the medically-prescribed injection device is authorized; and
using the prescription data received from the medically-prescribed injection device to enable as operable the one or more prescription-regulated operational features of the medically-regulated software application that are inoperable by default for use with the medically-prescribed injection device.
12. The method of claim 11 , wherein the medically-prescribed injection device includes a medicine injection pen and/or medicine injection pump.
13. The method of claim 11 , wherein the mobile device is implemented on a smartphone, a tablet, and/or a wearable device.
14. The method of claim 11 , wherein the medically-regulated software application is operable on the mobile device to cause the mobile device to display a default screen prior to enabling as operable the one or more prescription-regulated operational features.
15. The method of claim 14 , wherein the default screen includes one or more of an indicator that the pairing is undergoing, a list of trouble-shooting steps should the pairing be impaired or unsuccessful, or a contact information for a user to seek assistance with the pairing process.
16. The method of claim 11 , wherein the wireless transmission includes a signal in accordance with a Bluetooth, Bluetooth Low Energy (BLE), and/or Near Field Communication (NFC) protocol.
17. A method for enabling use of a medically-regulated software application for a mobile device with a medically-prescribed injection device, the method comprising:
determining that the medically-prescribed injection device is within a communication range of the mobile device so as to allow wireless communications between the medically-prescribed injection device and the mobile device, wherein the medically-regulated software application is stored on the mobile device and has one or more prescription-regulated operational features that are inoperable by default, and wherein the one or more prescription-regulated operational features, when executed, cause the mobile device to operate in a manner that is regulated to require a medical prescription for use of the medically-regulated software application;
at the medically-prescribed injection device, storing a prescription code in a memory of the medically-prescribed injection device, the prescription code configured to enable as operable the prescription-regulated operational features of the medically-regulated software application;
transmitting a wireless transmission including the prescription code from the medically-prescribed injection device to the mobile device during a pairing of the medically-prescribed injection device with the mobile device; and
at the medically-prescribed injection device, receiving a subsequent wireless transmission from the mobile device that includes an instruction to carry out a medically-regulated operation of the medically-prescribed injection device, wherein the instruction is transmitted by the mobile device as a result of a validation of the prescription code by the mobile device to enable as operable the one or more prescription-regulated operational features of the medically-regulated software application that are otherwise inoperable by default for use with the medically-prescribed injection device.
18. The method of claim 17 , wherein the medically-prescribed injection device includes a medicine injection pen and/or medicine injection pump.
19. The method of claim 17 , wherein the mobile device is implemented on a smartphone, a tablet, and/or a wearable device.
20. The method of claim 17 , wherein the wireless transmission includes a signal in accordance with a Bluetooth, Bluetooth Low Energy (BLE), and/or Near Field Communication (NFC) protocol.